Wed, Aug 14, 2019
Sun Pharma gets exclusive global license for CSIR-IICT’s patents related to certain compounds with potential therapeutic activity across multiple indications
More >
Fri, Jul 29, 2016
The pharmaceutical arm of Chinese conglomerate Fosun plans to buy a majority stake in India`s Gland Pharma Ltd. for as much as $1.26 billion, in what is being touted as the biggest Indian acquisition by a Chinese company.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.